Herb Cerebral embolism F5: Cerebral embolism stroke, atrophia, loss of voice or skin problems.
1. Stroke: 97 stroke patients took F5 or its modification for up to six weeks and 36 cured (37.11 percent), 24 significantly improved (24.74 percent), 28 improved (28.86 percent), six did not improve and three deaths (3.09 percent). Other 290 cerebral embolism patients took F5 for up to six weeks found 113 cured (38.96 percent), 106 significantly improved (36.55 percent), 62 improved (21.37 percent) and nine did not improve (3.10 percent).
2. Myelanalosis, tabes dorsalis or tabes: Four reports of 60 patients took F5 and all were improved.
3. Artophia: 121 patients took F5 or its modifications for up to 11 weeks and only five did not improve, other 116 were all improved (95.86 percent).
Toxicity and side effect: No toxicity or side effect has been reported on F5 formula.